Rainbow Children's Medicare showcases mixed results in financial performance and growth. While sales growth remains strong, profit growth has shown signs of deceleration. The company's revenue has consistently expanded, but its ability to convert these sales into profits is facing challenges.

Sales Growth: Rainbow Children's Medicare has demonstrated consistent sales growth over the years. The average sales growth from 2014 to 2016 was 38.28%, followed by 32.56% from 2017 to 2019 and 26.45% from 2020 to 2022. Although there is a decreasing trend in sales growth, the company manages to have a strong sales growth of 16.88% in Mar 2025.

Profit Growth: The compounded profit growth is 34% (5 Years) which decreased to 20% (3 Years). In the recent year Mar 2025 profit growth increased to 15% as compared to 3% in Mar 2024.

Rainbow Children's Medicare exhibits strong capital efficiency and good returns, reflected in its ROCE and ROE values. The company effectively utilizes its capital to generate profits, indicating sound management practices in resource allocation and investment.

ROCE: The Return on Capital Employed (ROCE) has fluctuated over the years but generally remains at a healthy level. In Mar 2016, ROCE was 11%, which increased to 16% by Mar 2019 and further to 23% by Mar 2022. However, there was a slight decrease to 19% by Mar 2024 which remains same in Mar 2025. The ROCE indicates the company's effectiveness in generating profits from its capital investments.

ROE: Return on Equity (ROE) for the current year is 17.20%. This demonstrates the company's ability to generate returns on shareholders' equity. A higher ROE indicates that the company is using shareholder investments effectively to generate profits.

Rainbow Children's Medicare showcases an average financial health profile. While the company demonstrates a capacity to share profits through dividends, its increasing debt levels and associated interest expenses present a moderate risk.

Debt Management: The Debt/Equity Ratio has seen fluctuations. The average Debt/Equity ratio from 2014-2016 was 0.14, which increased to 0.82 from 2017-2019 and further to 1.22 from 2020-2022. The Debt/Equity ratio is 0.53 in Mar 2025.

Interest Coverage Ratio: The Interest Coverage Ratio remained at 3.59 from 2020-2022. The Interest Coverage ratio is 6.42 in Mar 2025.

Dividend Payout: The Dividend Payout % is 13% in Mar 2025.

Rainbow Children's Medicare has a stable shareholding structure which indicates confidence and alignment with shareholders. The details of shareholding are:

Promoter Holding: The promoter holding is relatively stable at around 49.85% in Mar 2025.

Institutional Holding: FII holding is 23.69% and DII holding is 15.31% in Mar 2025.

Rainbow Children's Medicare experiences segment performance volatility, as evidenced by fluctuations in quarterly sales and profit growth. The YOY Sales Growth % and YOY Profit Growth % shows huge volatility.

Rainbow Children's Medicare may be exposed to foreign exchange or interest rate risks, as indicated by fluctuations in interest expenses. Interest expenses increased from ₹ 42 Cr. in Mar 2019 to ₹ 77 Cr. in Mar 2025.